Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
Mallinckrodt
Federal Trade Commission
Farmers Insurance
Chubb

Generated: August 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA Inc. (D. Del. 2010)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA Inc.
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up and ➤ Sign Up .

Details for Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA Inc. (D. Del. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-04-01 1 Letter. nunn gInfringement of United States Patent No. 5,849.911) 31. BMS and Novartis incorporate the preceding…an action for patent infringement of United States Patent Nos. 5,849,9]1 (“the ’911 patent”) and 6,087,…Revataz® Product and Related Patents 12. On December 15, 1998, the ’911 patent, titled “Antivirally Active…Khanna. Novartis is the owner of the ’911 patent 13. The ’911 patent is valid and enforceable 14. BMS has…exclusive license to the ’911 patent. 15. A true and correct copy of the ’911 patent is attached as Exhibit External link to document
2010-04-05 5 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,849,911; 6,087,383; (els) (…2010 24 October 2011 1:10-cv-00264 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Johnson and Johnson
US Department of Justice
Covington
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.